Commercial Due Diligence Private Equity Teams Need
Commercial due diligence in private equity has one practical purpose: to determine whether the revenue story can survive ownership, scale and scrutiny from the next buyer.
That makes it different from a market report. A market report can tell you that a category is growing. Strong commercial due diligence tells you whether this company can win a specific share of that growth, at an acceptable cost, with a repeatable commercial engine and a management team that can execute under a PE timeline.
The risk for sponsors is not only buying a business with weak demand. The bigger risk is buying a business where demand exists, but the company lacks the commercial infrastructure to capture it predictably. The CIM may show attractive growth. Management may describe a large pipeline. Customer references may sound positive. None of that is enough unless the evidence connects to revenue quality, margin expansion, sales productivity and exit readiness.
What commercial due diligence must prove
Commercial due diligence private equity teams need should answer four questions before IC: where will growth come from, how reliable is that growth, what must be fixed after close and how will those fixes affect the value creation plan?
That sounds straightforward, but diligence often becomes too broad. Teams collect market data, customer calls, competitor commentary and management presentations without forcing the evidence into a deal decision. Good CDD starts with the investment thesis, then tests the few assumptions that would materially change valuation, structure or post-close priorities.
If the deal thesis depends on enterprise expansion, diligence must test enterprise win rates, buying committees, implementation capacity, pricing power and competitive displacement. If the thesis depends on add-on acquisitions, diligence must test channel conflict, product integration risk and the maturity of the core sales engine. If the thesis depends on U.S. market expansion, diligence must test ICP fit, local buyer behavior, sales talent availability and the cost of acquiring early reference accounts.
Private equity ownership changes what matters commercially. Broad top-line growth gives way to revenue quality, repeatability and proof that the model can scale. That shift is explored in more depth in this guide to how business private equity changes commercial priorities, but the same principle applies during diligence: do not evaluate the company only as it is today. Evaluate whether it can become the company the investment case requires.
The five diligence questions that matter most
A useful CDD process does not try to prove everything. It isolates the commercial questions that could break the deal, improve the deal or define the first 100 days.
| Diligence question | Evidence that matters | Red flag |
|---|---|---|
| Is the market opportunity real and reachable? | Segment-level growth, buyer budgets, competitive intensity, customer switching behavior and barriers to entry | Large TAM with no clear path to reachable accounts |
| Is revenue high quality? | Cohort performance, retention, renewal behavior, customer concentration, gross margin by segment and recurring versus project revenue | Growth driven by one-time wins, founder relationships or low-margin accounts |
| Is the GTM engine repeatable? | Pipeline conversion, sales cycle data, win rates by source, rep productivity, CRM hygiene and qualification discipline | Pipeline volume looks strong, but stage definitions and close dates are unreliable |
| Does pricing support the value story? | Discounting patterns, price increases, margin leakage, willingness to pay and competitive alternatives | Sales teams rely on discounting to win or renew accounts |
| Can management execute the value creation plan? | Forecast accuracy, commercial cadence, role clarity, talent depth and decision rights | Leadership can explain growth, but cannot show an operating system behind it |
This table is not a checklist for a junior analyst to complete and file away. It is a pressure test for the investment case. If the evidence is weak in one area, the team must decide whether the risk can be mitigated through structure, price, post-close support or a revised thesis.
Evidence beats narrative
Management teams are usually optimistic during a process. That is normal. The role of commercial due diligence is not to treat every claim as suspicious, but to separate ambition from evidence.
Revenue should be cut by customer type, acquisition channel, product line, geography, cohort and gross margin contribution. A business growing at 20 percent can look very different once growth is separated into repeatable new logo acquisition, expansion from existing customers, price increases, pass-through costs and one-off project work.
Pipeline should be inspected in the same way. A large weighted pipeline is not a commercial asset if opportunities are stale, poorly qualified or dependent on a small number of senior relationships. PE teams should ask how each stage is defined, what exit criteria move a deal forward, how often opportunities slip, how many deals close without being in CRM and whether the same forecast categories mean the same thing across the sales team.
Customer interviews need equal discipline. Reference calls arranged by management are useful, but they are rarely sufficient. Diligence should include current customers, former customers, lost prospects, channel partners and buyers who chose competitors. The goal is not to collect compliments. The goal is to understand why customers buy, why they stay, why they leave and whether the company has pricing power when alternatives are available.
AI can accelerate desk research, market mapping and document review, but it cannot replace evidence. In AI-assisted diligence, teams must not confuse fluent summaries with verified facts. Public conversations around AI detection test resources show how hard it can be to judge authorship from a document alone, so the stronger control is source provenance, original citations, human review and clear ownership of every claim that reaches the IC memo.
How to test the sales engine
Many diligence processes under-test sales execution. They review market demand and customer sentiment, then assume the company can convert demand into revenue if the category remains healthy. That assumption creates problems after close.
A sales engine has capacity limits. If the value creation plan requires 30 percent new logo growth, the diligence team needs to know whether current headcount, ramp times, lead sources, sales management and enablement can support that target. Hiring more reps is not a strategy unless the company can recruit well, ramp predictably, assign territories intelligently and generate enough qualified demand for each seller.
Rep productivity is especially important. Averages can hide underperformance. One or two strong sellers may be carrying the number while newer reps fail to ramp. Founder-led deals may be counted as normal sales productivity even though they cannot be scaled. Channel-sourced revenue may look efficient until the team examines partner economics, dependency risk and end-customer ownership.
Forecast accuracy is another commercial truth test. A company that consistently misses its forecast may still be attractive, but the sponsor should not build a value creation plan on unreliable commercial data. Forecast misses can point to weak qualification, poor deal inspection, unclear buyer process, overreliance on late-stage heroics or a CRM that exists for reporting rather than management.
Pricing deserves its own scrutiny. Some companies grow by selling value. Others grow by buying revenue through discounting, custom work or unfavorable contract terms. Diligence should examine actual realized price, discount approval patterns, gross margin by account, renewal uplift, sales compensation incentives and the difference between list price and collected revenue.
Red flags that should affect the deal discussion
Commercial red flags are not always deal killers. Some are fixable and can become part of the value creation plan. Others should change the price, the structure or the conviction level. The key is to identify them before they become post-close surprises.
| Finding | What it may indicate | Possible deal response |
|---|---|---|
| Growth depends on a few large accounts | Customer concentration, weak new logo engine or relationship dependency | Adjust forecast confidence, test account durability and consider retention protections |
| Pipeline is large but poorly aged | Weak qualification, optimistic forecasting or stalled buyer demand | Rebuild pipeline assumptions and lower near-term revenue expectations |
| Sales performance is concentrated in one person | Founder-led growth or lack of institutionalized sales process | Plan for sales leadership support, process design and account transition risk |
| Discounts are common and inconsistent | Weak pricing governance or unclear value proposition | Test margin sensitivity and make pricing discipline a post-close priority |
| CRM data conflicts with management commentary | Low commercial visibility or immature operating cadence | Require deeper data validation before underwriting growth |
| Customer churn is explained away as unusual | Product fit issues, service gaps or wrong ICP | Segment churn carefully and test whether losses are isolated or structural |
These red flags are easier to manage when sponsors know what to look for early. For a deeper view of the warning signs that show up before they hit performance, see this discussion of how a PE sponsor spots commercial risk early.
The output should be a decision tool, not a thick report
A long CDD report can still be commercially weak. The best output is not the one with the most pages. It is the one that helps the deal team make better decisions.
A useful CDD output should connect findings directly to underwriting, value creation and ownership actions. If diligence finds that enterprise buyers have longer sales cycles than management assumed, that should flow into the model. If customer interviews show strong product love but weak executive-level value articulation, that should shape the post-close commercial plan. If pricing analysis reveals margin leakage, that should become a quantified upside case or a downside protection issue.
The final output should usually include four practical components:
| Output | What it should clarify |
|---|---|
| Thesis validation | Which parts of the investment thesis are supported, unsupported or still uncertain |
| Revenue risk register | The commercial risks most likely to affect growth, margin or exit narrative |
| Value creation implications | The actions required after close, ranked by urgency, impact and execution complexity |
| IC-ready evidence | The customer, market, GTM and pricing proof that supports the recommendation |
This format makes CDD harder to ignore after the deal closes. It also prevents the common failure where diligence identifies issues, but the ownership team never converts them into operating cadence, leadership priorities or measurable commercial milestones.
Turning diligence into the first 100 days
Commercial due diligence creates the most value when it becomes the bridge into post-close execution. A sponsor should be able to look at the diligence findings and know what must happen in the first 30, 60 and 100 days.
The first 30 days should focus on commercial truth. That means validating the data room against live operating data, aligning management around the real ICP, confirming pipeline quality and identifying which revenue metrics will govern the business. The goal is not to redesign everything immediately. The goal is to establish facts and stop managing through anecdote.
By day 60, the company should be tightening the GTM system. This may include clarifying segment priorities, improving qualification criteria, tightening sales management cadence, reviewing pricing governance and identifying talent gaps. The sponsor should know whether the original value creation assumptions still hold or need adjustment.
By day 100, diligence should have translated into measurable commercial infrastructure. That could include a cleaner forecast process, stronger pipeline inspection, clearer account ownership, revised sales compensation or a prioritized market expansion plan. The specific actions depend on the deal thesis, but the principle is constant: commercial due diligence should not end at signing.
Frequently Asked Questions
What is commercial due diligence in private equity? Commercial due diligence is the process of testing a company’s market position, revenue quality, customer behavior, competitive dynamics, pricing power and GTM repeatability before an investment decision. In PE, it should also inform valuation, deal structure and the post-close value creation plan.
How is commercial due diligence different from financial due diligence? Financial diligence validates historical financial performance, accounting quality, working capital, debt-like items and earnings adjustments. Commercial diligence tests whether future revenue assumptions are credible, scalable and defensible in the market.
When should PE teams start commercial due diligence? PE teams should start commercial thinking before exclusivity when possible. Early screening should identify the biggest commercial assumptions, then deeper diligence can test those assumptions through data analysis, customer interviews, market work and GTM review.
What are the most common CDD blind spots? Common blind spots include overreliance on management’s pipeline, weak testing of sales productivity, limited lost-customer interviews, insufficient pricing analysis and failure to connect diligence findings to the first 100 days.
Can AI improve commercial due diligence? AI can help accelerate document review, market mapping, competitor scans and synthesis, but it should not replace source validation, customer interviews or expert commercial judgment. Every material claim should be traceable to credible evidence.
Need sharper commercial due diligence before IC?
Phil Pelucha Consulting helps PE firms, family offices and portfolio companies improve commercial clarity, revenue acceleration and exit readiness. If you need a stronger view of revenue risk, GTM repeatability, market expansion potential or post-close commercial priorities, Phil Pelucha Consulting can support sponsor-level decision-making with practical commercial diagnostics and execution-focused advisory.